INS and neoplasm: Moreover, glucose uptake was also inhibited after TZL treatment in a PKCθ-dependent manner (5 μM, 16 h; Figure 4D), suggesting that TZL limits tumor cells access to glucose by inducing an insulin resistant phenotype via activation of PKCθ.